| CAS ID: | 2226993-88-8 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | SPX-101 |
| Analysis: | N/A |
Reference Record 1
| PubMed ID | 28984146 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,rat | Fibrosis Disease | Cystic fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 2
| PubMed ID | 28481660 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice,pup,sheep | Fibrosis Disease | Cystic fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | Targeting ENaC | ||
Trial Record 1
| ClinicalTrial ID | NCT03056989 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | February 17, 2017 | Last Verified | September 5, 2017 |
| Sponsor | Spyryx Biosciences, Inc. | ||
Trial Record 2
| ClinicalTrial ID | NCT03229252 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Recruiting |
| First Received | July 25, 2017 | Last Verified | March 19, 2019 |
| Sponsor | Spyryx Biosciences, Inc. | ||